Gerwin Huls, MD PhD
University Medical Center Groningen · Radboud University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gerwin Huls, MD PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:04 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04099901 · Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled TrialRadboud University Medical Center · completed · Multiple Myeloma · principal investigator
- Ph2NCT02252107 · 10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1Radboud University Medical Center · completed · Acute Myeloid Leukemia (AML) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.